WallStSmart

The Clorox Company (CLX)vsKenvue Inc. (KVUE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 126% more annual revenue ($15.29B vs $6.76B). CLX leads profitability with a 11.2% profit margin vs 10.6%. KVUE appears more attractively valued with a PEG of 1.42. KVUE earns a higher WallStSmart Score of 68/100 (B-).

CLX

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 5/9Altman Z: 2.07

KVUE

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-22.9%)

Margin of Safety

-22.9%

Fair Value

$102.51

Current Price

$94.14

$8.37 premium

UndervaluedFair: $102.51Overvalued
KVUESignificantly Overvalued (-87.1%)

Margin of Safety

-87.1%

Fair Value

$9.91

Current Price

$17.71

$7.80 premium

UndervaluedFair: $9.91Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX3 strengths · Avg: 9.3/10
Return on EquityProfitability
54.6%10/10

Every $100 of equity generates 55 in profit

Debt/EquityHealth
-66.9610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.7x8/10

Attractively priced relative to earnings

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

Areas to Watch

CLX4 concerns · Avg: 3.5/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Free Cash FlowQuality
$-165.00M2/10

Negative free cash flow — burning cash

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, Debt/Equity, P/E Ratio.

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.55 — expect wider price swings.

KVUE is growing revenue faster at 4.5% — sustainability is the question.

KVUE generates stronger free cash flow (350M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (68/100 vs 57/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Want to dig deeper into these stocks?